D-0246-2021 Class II Terminated

Recalled by Taro Pharmaceuticals U.S.A., Inc. — Hawthorne, NY

Recall Details

Product Type
Drugs
Report Date
February 10, 2021
Initiation Date
January 8, 2021
Termination Date
September 7, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
44,256 bottles

Product Description

Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532 NDC 51672-4001-1

Reason for Recall

CGMP deviations.

Distribution Pattern

Nationwide

Code Information

AC05096, AC05098, and AC05099; Exp 10/31/2022